Stimulant Use Disorders: Developing Drugs for Treatment
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 5, 2023
October 5, 2023
396da81b-e089-444c-9781-b40a43a1cff2
Related Documents
Erosive Esophagitis: Developing Drugs for Treatment
Guidance DocumentSeptember 17, 2025Center for Drug Evaluation and Research
Migraine: Developing Drugs for Preventive Treatment
Guidance DocumentJune 1, 2023Center for Drug Evaluation and Research
Endogenous Cushing’s Syndrome: Developing Drugs for Treatment
Guidance DocumentSeptember 8, 2023Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.